People: Furiex Pharmaceuticals Inc (FURX.O)
7 Mar 2014
Dr. Peter B. Corr, Ph.D. is Independent Director of Furiex Pharmaceuticals Inc. He is Co-Founder and Managing General Partner of Auven Therapeutics Management, L.L.L.P., previously known as Celtic Therapeutics Management L.L.L.P. Dr. Corr retired from Pfizer Inc. in December 2006 where he was Senior Vice President for Science and Technology, a position he had held since 2002. He also headed worldwide pharmaceutical research and development for Pfizer. Previously, Dr. Corr served as Executive Vice President, Pfizer Global Research & Development, and President, Worldwide Development. Prior to Pfizer, Dr. Corr served as Senior Vice President, Discovery Research, at Monsanto/Searle and President of Pharmaceutical Research and Development at Warner Lambert/Parke Davis. Dr. Corr, who received his Ph.D. from Georgetown University School of Medicine, spent 18 years as a researcher in molecular biology and pharmacology at Washington University in St. Louis. When he left Washington University, Dr. Corr was Professor, Department of Medicine (Cardiology) and Professor, Department of Pharmacology and Molecular Biology. His research has been published in more than 160 scientific manuscripts. In addition to his work at Pfizer, Dr. Corr was Chairman of the Science & Regulatory Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA); Chairman of the PhRMA Foundation Board of Directors; and Chairman of the Hever Group for several years, representing Chief Scientific Officers (CSOs) across the European and U.S. based pharmaceutical industry.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|